Tag: customizable
-
Docker: Building AI agents made easy with Goose and Docker
Source URL: https://www.docker.com/blog/building-ai-agents-with-goose-and-docker/ Source: Docker Title: Building AI agents made easy with Goose and Docker Feedly Summary: Building AI agents can be a complex task. But it also can be a fairly simple combination of answers to the following questions: What is the AI backend that powers my intelligent fuzzy computation? What tools do you…
-
AWS News Blog: Minimize AI hallucinations and deliver up to 99% verification accuracy with Automated Reasoning checks: Now available
Source URL: https://aws.amazon.com/blogs/aws/minimize-ai-hallucinations-and-deliver-up-to-99-verification-accuracy-with-automated-reasoning-checks-now-available/ Source: AWS News Blog Title: Minimize AI hallucinations and deliver up to 99% verification accuracy with Automated Reasoning checks: Now available Feedly Summary: Build responsible AI applications with the first and only solution that delivers up to 99% verification accuracy using sound mathematical logic and formal verification techniques to minimize AI hallucinations…
-
AWS News Blog: AWS AI League: Learn, innovate, and compete in our new ultimate AI showdown
Source URL: https://aws.amazon.com/blogs/aws/aws-ai-league-learn-innovate-and-compete-in-our-new-ultimate-ai-showdown/ Source: AWS News Blog Title: AWS AI League: Learn, innovate, and compete in our new ultimate AI showdown Feedly Summary: AWS AI league is a program that helps organizations upskill their workforce by combining fun competition with hands-on learning using AWS AI services. It offers a unique opportunity for both enterprises and…
-
Slashdot: Google DeepMind’s Spinoff Company ‘Very Close’ to Human Trials for Its AI-Designed Drugs
Source URL: https://science.slashdot.org/story/25/07/06/2124226/google-deepminds-spinoff-company-very-close-to-human-trials-for-its-ai-designed-drugs Source: Slashdot Title: Google DeepMind’s Spinoff Company ‘Very Close’ to Human Trials for Its AI-Designed Drugs Feedly Summary: AI Summary and Description: Yes Summary: The text illustrates the significant advancements in AI-driven drug discovery, particularly highlighting Isomorphic Labs’ plans to initiate human clinical trials using AI-designed drugs. This aligns closely with the…